Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib ( <scp>FGF401</scp> ) drug treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Contribution of machine learning to tumor growth inhibition modeling for hepatocellular carcinoma patients under Roblitinib ( FGF401 ) drug treatment

Published:2022-06-21 Issue:8 Volume:11 Page:1122-1134
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacom & Syst Pharma

Author:

Wilbaux Mélanie¹,Demanse David²,Gu Yi³,Jullion Astrid²,Myers Andrea⁴,Katsanou Vasiliki⁵,Meille Christophe²^ORCID

Affiliation:

1. Pharmacometrics Novartis Basel Switzerland

2. Early Development Analytics Novartis Basel Switzerland

3. Pharmacokinetic Sciences Novartis Institutes for Biomedical Research Cambridge USA

4. Clinics Novartis Shanghai China

5. Clinical Operations Novartis Basel Switzerland

Funder

Novartis

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12831

Reference41 articles.

1. A Review of Modeling Approaches to Predict Drug Response in Clinical Oncology

2. Deep learning

3. The rise of deep learning in drug discovery

4. Applications of machine learning in drug discovery and development

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical decision support for chemotherapy‐induced neutropenia using a hybrid pharmacodynamic/machine learning model;CPT: Pharmacometrics & Systems Pharmacology;2023-08-10

2. Integration of Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy into Model‐Informed Dose Selection in Oncology First‐in‐Human Study: A Case of Roblitinib ( FGF401 );Clinical Pharmacology & Therapeutics;2022-10-18

3. A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections;Antimicrobial Agents and Chemotherapy;2022-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3